Abstract

Despite having an exceptionally high fluorine (F) concentration in their bones (up to 9000 µg/g in the present study), radiographs of mature Ade?lie penguins (Pygoscelis adeliae) do not show any symptoms of skeletal fluorosis. In this research, a series of chemical fractionation and speciation analyses for F gave a tentative explanation for this seemingly abnormal fact. The results showed that the inorganic fraction of F in penguin bones represented only about one-third of the total F with the rest bound organically, mostly in the form of fluorinated chitin or its derivatives. A laboratory experiment with rats on a high F intake indicated that chitin might prevent skeletal fluorosis by effectively combining with F and inhibiting abnormal mineralization, thereby decreasing the expected increase in bone mineral density.

• Related Studies :

  • Fluoride exposure altered metabolomic profile in rat serum

    Highlights 58 NEG and 73 POS metabolites were altered in F-treated 3 weeks rat serum. 126 NEG and 70 POS metabolites were altered in F-treated 11 weeks rat serum. Four significantly different metabolites, nicotinamide, adenosine, 1-Oleoyl-sn-glycero-3-phosphocholine, and 1-Stearoyl-sn-glycerol 3-phosphocholine were shared by two models. Urea, N2-Acetyl-l-ornithine, and betaine were

  • Further observations on endemic fluoride-induced osteopathies in children

    Fluoro-osteopathy has been described in four clildren aged 6 or above, These observations contrast with the concept that skeletal fluorosis cannot develop prior to 10 to 20 years of high fluoride intake. The pathogenesis and the mechanism underlying the causation of this disease is discussed on the basis of the

  • Expression of core-binding factor a1 and osteocalcin in fluoride-treated fibroblasts and osteoblasts

    To study the effects and importance of fluoride on FBs in the development of extraperiosteal calcification and the ossification of skeletal fluorosis, the presence of the osteogenic phenotype, which is indicated by the expression of core-binding factor a1 (Cbfa1) and osteocalcin (OCN), in an FB cell line (L929) and in

  • [Scan microscopic investigation of human industrial fluorosis (author's transl)].

    We examined the bones of 3 people in various stages of industrial fluorosis. Scan microscopic studies were conducted on the periosteal surface and the fracture surfaces of ribs, tibia and vault of the cranium. In the mild form of fluorosis, we found slight swelling and impregnation with globular and crystalline

  • Industrial fluorosis [Franke et al.]

    This is a review of findings on workers in an aluminum plant with industrial fluorosis. Early signs of the disease are nocturnal back pains and restriction of the rotation of the trunk. Stage I of the disease usually occurs after 10 years, stage II after 15 years and stage III

• Related FAN Content :

  • Skeletal Fluorosis: The Misdiagnosis Problem

    It is a virtual certainty that there are individuals in the general population unknowingly suffering from some form of skeletal fluorosis as a result of a doctor's failure to consider fluoride as a cause of their symptoms. Proof that this is the case can be found in the following case reports of skeletal fluorosis written by doctors in the U.S. and other western countries. As can be seen, a consistent feature of these reports is that fluorosis patients--even those with crippling skeletal fluorosis--are misdiagnosed for years by multiple teams of doctors who routinely fail to consider fluoride as a possible cause of their disease.

  • Fluoride & Osteoarthritis

    While the osteoarthritic effects that occurred from fluoride exposure were once considered to be limited to those with skeletal fluorosis, recent research shows that fluoride can cause osteoarthritis in the absence of traditionally defined fluorosis. Conventional methods used for detecting skeletal fluorosis, therefore, will fail to detect the full range of people suffering from fluoride-induced osteoarthritis.

  • "Pre-Skeletal" Fluorosis

    As demonstrated by the studies below, skeletal fluorosis may produce adverse symptoms, including arthritic pains, clinical osteoarthritis, gastrointestinal disturbances, and bone fragility, before the classic bone change of fluorosis (i.e., osteosclerosis in the spine and pelvis) is detectable by x-ray. Relying on x-rays, therefore, to diagnosis skeletal fluorosis will invariably fail to protect those individuals who are suffering from the pre-skeletal phase of the disease. Moreover, some individuals with clinical skeletal fluorosis will not develop an increase in bone density, let alone osteosclerosis, of the spine. Thus, relying on unusual increases in spinal bone density will under-detect the rate of skeletal fluoride poisoning in a population.

  • Fluoride & Arthritis

    The doses that American adults now routinely ingest overlap the doses that may cause chronic joint pain.

  • Fluoride & Spinal Stenosis

    Spinal stenosis is a narrowing of the spaces in the spine that results in pressure being placed on the spinal cord and/or nerve roots. Although stenosis can develop without symptoms, it may produce numbness, tingling, pain and difficulty in walking, as well as a heavy/tired feeling in the legs. It is estimated that 250,000 to 500,000 Americans currently have symptoms of spinal stenosis. Skeletal fluorosis is one cause of stenosis.